|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 263 articles |
 Page 1 of 4 
|
Antisoma's AS1411 impresses in AML.
December 17, 2007
Jordan's Hikma to buy APM for $164M.
December 17, 2007
Novartis plans cutbacks to reduce red tape.
December 17, 2007
ImClone/Sanofi sign $120M Yeda settlement.
December 17, 2007
ImmunoVaccine to acquire Immunotope.
December 17, 2007
OncoMed signs $1.4B MAb deal with GSK.
December 17, 2007
GSK licenses Galapagos' anti-infectives.
December 17, 2007
FDA pre-emption case at the US Supreme Court.
December 17, 2007
US Endocrine Society call for more CT diversity.
December 17, 2007
Pharma opposed to Japan's recalculation method with market expansion.
December 17, 2007
WHO intensifies efforts on child-appropriate medicines, which are supp...
December 17, 2007
Inconclusive OFT report on UK DTP distribution.
December 17, 2007
Enrollment complete in Ph II/III DuoCort trial.
December 17, 2007
AstraZeneca highlights international development as key to sustained s...
December 17, 2007
B-MS to cut 10% of workforce in a bid to save $1.5B in time for loss o...
December 17, 2007
GPC to lose 44% of US and German staff.
December 17, 2007
Telvancin non-inferior in HAP/VAP studies.
December 17, 2007
Amylin/ lilly plan Byetta monotherapy filing.
December 17, 2007
Remoxy meets pain reduction goal in trial.
December 17, 2007
Promacta raises platelet counts in HCV and ITP.
December 17, 2007
PhRMA details Mexico flood relief by members.
December 17, 2007
Medicare reimbursement change criticized.
December 17, 2007
"Essential" R&D tax credit says PhRMA.
December 17, 2007
Free US generic drug program ends.
December 17, 2007
BioInvest desgnates BI-505 for cancer treatment.
December 17, 2007
Roche and ARK to collaborate on HIV drug monitoring prod.
December 17, 2007
Merck KGaA's 4.9B-euro sale of generics ops to Mylan completes.
December 17, 2007
Medgenics starts trading on AIM.
December 17, 2007
Discovery Labs raises $25 million.
December 17, 2007
Neurocrine leases real estate assets for $61M.
December 17, 2007
FDA panel advises tetrabenazine approval.
December 17, 2007
TargeGen plans to initiate TG101348 trials early next year.
December 17, 2007
ImmuPharma to split US Ph II and III SLE drug trials.
December 17, 2007
Decision Resources to buy Wood Mackenzie life sciences business.
December 17, 2007
OXiGENE gives update on Zybrestat.
December 17, 2007
Clinical Data pays milestone to Merck KGaA.
December 17, 2007
Final OK for OTC omeprazole, and Perrigo ups guidance.
December 17, 2007
Trimeris reveals strategic plan.
December 17, 2007
Exjade cuts high iron levels in b-thalassemia.
December 17, 2007
EUSA Pharma enters $30M financing round.
December 17, 2007
Fourth Genmab/Roche Ab enters clinic in USA.
December 17, 2007
Canada's govt blamed for high generic prices.
December 17, 2007
Vietnam welcomes foreign drugmakers.
December 17, 2007
Stock Commentary - Europe - week to Dec 10, 2007.
December 17, 2007
Stock Commentary - New York week to Dec 10, 2007.
December 17, 2007
Eli Lilly's 2008 EPS forecast beats expectations as firm prepares for ...
December 17, 2007
UPDATE: MedImmune's biologics capabilities to boost AstraZeneca's flag...
December 17, 2007
UK's PMCPA names six firms in violation of Code.
December 17, 2007
Amgen in discussions to update US ESA labels.
December 17, 2007
YouTube immunization videos: negative are best.
December 17, 2007
ABPI invites comment on UK Code of Practice.
December 17, 2007
EFPIA push for health information strategy.
December 17, 2007
Compulsory licensing and access to drugs - the Rwanda experience by Ma...
December 17, 2007
The top health-related stories of 2007 - as viewed by the Harvard Heal...
December 17, 2007
Olmetec first ARB to show sclerotic regress.
December 17, 2007
BioLineRx licenses BL-5010 to Innovative Pharmaceutical.
December 17, 2007
Genzyme hoping to expand Clolar into adult AML.
December 17, 2007
P&G reports strong UC data on Asacol.
December 17, 2007
Genes linked to MS severity.
December 17, 2007
Zevalin boosts PFS in follicular lymphoma.
December 17, 2007
Rivaroxaban cuts VTE risk in RECORD-1 trial.
December 17, 2007
Boeh Ing to study dabigatran etexilate in ACS.
December 17, 2007
FDA fast-track for Osiris' Prochymal.
December 17, 2007
Safety board backs continuation of TroVax Ph III.(Clinical report)
December 17, 2007
Novo Nordisk launches Changing Diabetes Barometer.
December 17, 2007
ImmunoGen's candidates produce "encouraging results".
December 17, 2007
Amgen's romiplostim meets Phase III endpoints in ITP.(Clinical report)
December 17, 2007
Angus Russell names as new Shire CEO.
December 17, 2007
ProStrakan's co-founder Harry Stratford to step down this year.
December 17, 2007
Trevor Jones named as Synexus chairman.
December 17, 2007
Questcor appoints Don Bailey as CEO.
December 17, 2007
GSK to set up L50M Chinese neuroscience center.
December 17, 2007
Novartis announces a further 2,500 job cuts.
December 17, 2007
Biogen fails to attract "definitive offer".
December 17, 2007
Mixed late-stage data on B-MS/Medarex' ipilimumab.
December 17, 2007
|
1